Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-19 Sale |
2023-09-21 4:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
5,651 | $351 | $1,983,501 | 51,905 (Direct) |
View |
| 2023-09-05 Sale |
2023-09-07 4:29 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
5,651 | $352.66 | $1,992,882 | 57,556 (Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:14 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,500 | $355 | $887,500 | 48,637 (Direct) |
View |
| 2023-08-10 Sale |
2023-08-14 4:09 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kearney Terrence C Director |
10,000 | $350 | $3,500,000 | 16,536 (Direct) |
View |
| 2023-08-10 Sale |
2023-08-14 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
5,750 | $345.79 | $1,988,293 | 51,137 (Direct) |
View |
| 2023-08-10 Sale |
2023-08-14 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
10,031 | $350 | $3,510,850 | 66,261 (Indirect Direct) |
View |
| 2023-08-09 Sale |
2023-08-11 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
63 | $345.51 | $21,767 | 32,038 (Direct) |
View |
| 2023-08-09 Sale |
2023-08-11 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
242 | $345.51 | $83,613 | 4,386 (Direct) |
View |
| 2023-07-17 Sale |
2023-07-18 4:17 pm |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
11,250 | $356.75 | $4,013,459 | 65,775 (Direct) |
View |
| 2023-07-17 Sale |
2023-07-18 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
7,828 | $355 | $2,778,940 | 118,906 (Direct) |
View |
| 2023-06-15 Sale |
2023-06-20 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
8,603 | $349 | $3,002,447 | 65,299 (Indirect Direct) |
View |
| 2023-05-30 Sale |
2023-06-01 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
82 | $329.82 | $27,045 | 56,696 (Indirect Direct) |
View |
| 2023-05-30 Sale |
2023-06-01 4:12 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
289 | $329.82 | $95,318 | 6,838 (Direct) |
View |
| 2023-05-05 Sale |
2023-05-09 4:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
3,272 | $350 | $1,145,213 | 32,038 (Direct) |
View |
| 2023-05-05 Sale |
2023-05-09 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
2,004 | $349.25 | $699,887 | 35,827 (Indirect Direct) |
View |
| 2023-05-02 Sale |
2023-05-04 4:51 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
4,403 | $350.71 | $1,544,187 | 35,310 (Direct) |
View |
| 2023-05-02 Sale |
2023-05-04 4:50 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
10,958 | $349.98 | $3,835,062 | 37,831 (Indirect Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 5:01 pm |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
1,449 | $0 | $0 | 7,377 (Indirect Direct) |
View |
| 2023-05-02 Sale |
2023-05-03 4:44 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
580 | $348.28 | $202,004 | 4,628 (Direct) |
View |
| 2023-04-27 Sale |
2023-05-01 4:26 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
3,317 | $339.08 | $1,124,726 | 126,652 (Direct) |
View |
| 2023-04-12 Sale |
2023-04-14 4:19 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
7,567 | $326.7 | $2,472,164 | 39,713 (Direct) |
View |
| 2023-04-12 Sale |
2023-04-14 4:14 pm |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
21,300 | $326.73 | $6,959,422 | 40,000 (Direct) |
View |
| 2023-04-04 Sale |
2023-04-06 4:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
522 | $315.81 | $164,854 | 47,280 (Direct) |
View |
| 2023-03-24 Sale |
2023-03-28 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
1,768 | $305.38 | $539,912 | 49,611 (Direct) |
View |
| 2023-03-17 Sale |
2023-03-21 4:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
2,000 | $296.39 | $592,786 | 51,379 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 4:26 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
2,746 | $300.59 | $825,423 | 49,268 (Direct) |
View |
| 2023-03-10 Sale |
2023-03-14 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
4,754 | $291.98 | $1,388,054 | 53,379 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2023-09-05 4:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
0 | $0 | 13,879 (Direct) |
View |
| 2023-08-10 Exercise |
2023-08-14 4:09 pm |
N/A 2025-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | Kearney Terrence C Director |
10,000 | $0 | 16,536 (Direct) |
View |
| 2023-08-10 Exercise |
2023-08-14 4:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kearney Terrence C Director |
10,000 | $127.54 | 16,536 (Direct) |
View |
| 2023-07-17 Exercise |
2023-07-18 4:17 pm |
N/A 2025-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
11,250 | $0 | 65,775 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-18 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
125 | $350.79 | 65,775 (Direct) |
View |
| 2023-07-17 Exercise |
2023-07-18 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
11,250 | $127.54 | 65,775 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-18 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
90 | $350.79 | 4,656 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-20 4:07 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
8,603 | $0 | 65,299 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-20 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
8,603 | $187.53 | 65,299 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 5:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director |
1,168 | $0 | 2,726 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 5:05 pm |
N/A 2033-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
3,481 | $0 | 3,481 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 5:01 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
2,617 | $0 | 7,377 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 4:59 pm |
N/A 2033-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
3,481 | $0 | 3,481 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 4:57 pm |
N/A 2033-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
3,481 | $0 | 3,481 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 4:55 pm |
N/A 2033-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Kearney Terrence C Director |
3,481 | $0 | 3,481 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 4:52 pm |
N/A 2033-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Garber Alan M Director |
2,325 | $0 | 8,215 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 4:46 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | CARNEY LLOYD Director |
1,168 | $0 | 5,318 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-03 4:44 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
1,168 | $0 | 4,628 (Direct) |
View |
| 2023-04-14 Option Award |
2023-04-18 5:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
131 | $332.77 | 14,400 (Direct) |
View |
| 2023-04-14 Option Award |
2023-04-18 5:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
90 | $332.77 | 3,118 (Direct) |
View |
| 2023-04-12 Exercise |
2023-04-14 4:14 pm |
N/A 2024-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
21,300 | $0 | 40,000 (Direct) |
View |
| 2023-04-13 Gift |
2023-04-14 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
1,210 | $0 | 40,000 (Direct) |
View |
| 2023-04-12 Exercise |
2023-04-14 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
21,300 | $72.14 | 40,000 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 4:20 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,466 | $313.74 | 47,802 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
176 | $313.74 | 7,127 (Direct) |
View |